









Nightingale Signs Agreements to Serve 190 Healthcare Practitioners Across North America in its Fiscal 2011 Third Quarter


🞛 This publication is a summary or evaluation of another publication
MARKHAM, ON, Feb. 7 /CNW/ - Nightingale Informatix Corporation (TSX-V: NGH) ("Nightingale" or the "Company"), an application service provider (ASP) of Electronic Medical Record (EMR) software and related services today announced that during its fiscal 2011 third quarter ended December 31, it signed agreements to deploy 190 Seats of its Nightingale On Demand EMR and Practice Management solution to healthcare providers across Canada and the US (A "Seat" is defined as a paying healthcare provider using Nightingale's Electronic Medical Record). Included in these Seats is an enterprise agreement with a specialized care center in upstate New York, a large Cardiology practice in Ontario, and a large Nephrology practice in Ontario.
"We are pleased with the success we have had adding new EMR customers to date this fiscal year, and we believe we are positioned to further expand our presence throughout North America," said Sam Chebib, President & CEO of Nightingale. "Both the Canadian and US EMR markets offer significant further growth potential for us. We have achieved certification across various jurisdictions in Canada, including Saskatchewan, Ontario and Nova Scotia, and we expect to receive our Office of the National Coordinator (ONC) meaningful use certification for our EMR solution in the US in the next few months."
A substantial number of the EMR agreements Nightingale signed in the quarter are with Ontario-based clinics that are being supported through OntarioMD's EMR implementation funding program. This quarter in particular, Nightingale experienced an increase in the uptake of its EMR by Ontario-based specialists, due in part to their growing awareness of the funding that is available to them, and the Company's strong track record of implementing physicians successfully through its Fanatical Customer Service program. The Company signed EMR agreements across multiple specialties, including cardiology, endocrinology, orthopedic surgery, neurology, internal medicine and nephrology, among other specialties. The flexibility of Nightingale On Demand to tailor functionalities to meet the clinical and research needs of a specialty was key in Nightingale winning these contracts.
Mr. Chebib added: The availability of government funding remains a catalyst for EMR adoption. However, we are also starting to see a wider recognition among physicians of the real value EMR technology brings to medical practices. Although there may still be some near-term fluctuations, we anticipate that North American healthcare practitioners' adoption of EMR will continue to gain momentum, as we truly enter the phase of mass adoption."
About Nightingale Informatix Corporation
Nightingale is one of the fastest growing health care service and software companies in North America. It is recognized as an industry leader in Web-based (ASP) clinician and community based electronic medical records (EMR) serving the needs of small primary care practices, multi-physician outpatient clinics, and large scale regional health organizations and networks. Coupled with integrated practice management, transcription and revenue cycle management, Nightingale's comprehensive service offering allows customers to enhance patient care, increase revenue opportunities and optimize operations. Nightingale is continuously innovating and enhancing its services to meet the needs of its growing and diverse customer base. Nightingale - Healthcare connected. [ www.nightingalemd.com ]
This press release contains "forward-looking statements" respecting the issuance and cancellation of securities of the Company within the meaning of applicable Canadian securities legislation. Generally, forward-looking statements can be identified by the use of forward- looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may" ,"could", "would", "might" or "will be taken", "occur" or "be achieved". Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Nightingale to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: risks related to the speculative nature of the medical software industry, which is affected by numerous factors beyond Nightingale's control; the ability of Nightingale to successfully integrate its acquisitions and any liabilities arising as a result of such acquisitions, access to capital and agreements with its Lenders; the existence of present and possible future government regulation; access to debt or equity financing and agreements with its Lenders; the significant and increasing competition that exists in the medical software industry; the early stage of Nightingale's business; and therefore it is subject to the risks associated with early stage companies, including uncertainty of revenues, markets and profitability and the need to raise additional funding. All material assumptions used in making forward-looking statements are based on management's knowledge of current business conditions and expectations of future business conditions and trends. Although management believes the assumptions used to make such statements are reasonable at this time, our assumptions may not to be as anticipated, estimated or intended. Certain material factors or assumptions applied by management in making forward-looking statements, include without limitation, factors and assumptions regarding Nightingale's continued ability to fund its business, rates of customer defaults, relationships with, and payments to, lenders, demand for Nightingale's products, as well as Nightingale's operating cost structure.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.